Full metadata record
DC Field | Value | Language |
---|---|---|
dc.creator | Lopez-de-la-Mesa, R. (R.) | - |
dc.creator | Sierrasesumaga, L. (Luis) | - |
dc.creator | Calasanz-Abinzano, M.J. (Maria Jose) | - |
dc.creator | Lopez-de-Cerain, A. (Adela) | - |
dc.creator | Patiño-García, A. (Ana) | - |
dc.date.accessioned | 2012-11-21T12:57:05Z | - |
dc.date.available | 2012-11-21T12:57:05Z | - |
dc.date.issued | 2000 | - |
dc.identifier.citation | López de Mesa R, Sierrasesúmaga L, Calasanz MJ, López de Cerain AL, Patiño-García A. Nonclonal chromosomal aberrations induced by anti-tumoral regimens in childhood cancer: relationship with cancer-related genes and fragile sites. Cancer Genet Cytogenet. 2000 Aug;121(1):78-85. | es_ES |
dc.identifier.issn | 0165-4608 | - |
dc.identifier.uri | https://hdl.handle.net/10171/23757 | - |
dc.description.abstract | Cytogenetic studies were performed on 80 pediatric cancer patients to observe the chromosomal damage, both quantitative and qualitative, induced by chemotherapy. Peripheral blood lymphocytes (PBL) (n = 127) were obtained at diagnosis, during treatment, at remission, and at relapse, and chromosome analysis performed utilizing G-banding standard procedures. The results show a significant increase in the number of altered karyotypes (P = 0.03) in the samples during treatment, returning to values that were similar to those at diagnosis at 2-year remission. Most of the chromosomal aberrations (CA) detected during the chemotherapy regimens were nonclonal, unbalanced (75%), and involved chromosomes 1, 3, 5, 6, 11, 12, 16, and 17 most frequently. There was also a marked increase of CA in samples at relapse with very similar features (type and distribution) to those detected during treatment. There was a good correlation between the chromosomal breakpoints in our series and fragile sites (58%), oncogene (75%), and tumor suppressor gene (33%) loci described in the literature. The results obtained suggest that cytostatic drugs induce a transient increase in chromosome fragility occurring at several cancer-associated breakpoints. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Elsevier | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.subject | Chromosome Aberrations | es_ES |
dc.subject | Chromosome Fragility | es_ES |
dc.subject | Lymphocytes/drug effects/ultrastructure | es_ES |
dc.title | Nonclonal Chromosomal Aberrations Induced by Anti-Tumoral Regimens in Childhood Cancer: Relationship with Cancer-Related Genes and Fragile Sites | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.type.driver | info:eu-repo/semantics/article | es_ES |
dc.identifier.doi | http://dx.doi.org/10.1016/S0165-4608(00)00236-3 | es_ES |
Files in This Item:
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.